Atlas Trials

Laboratoires Thea

62 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Laboratoires Thea

RecordFirmDate
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis (NCT07169695)Laboratoires Thea2026-03-24
Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression (NCT07522242)Laboratoires Thea2026-01-21
A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study (NCT07234318)Laboratoires Thea2026-01-20
Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery (NCT07234292)Laboratoires Thea2025-10-30
New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye (NCT06903741)Laboratoires Thea2025-10-21
Real-world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP® (NCT07206628)Laboratoires Thea2025-09-19
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) (NCT06891443)Laboratoires Thea2025-06-04
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease (NCT07007702)Laboratoires Thea2025-01-27
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (NCT06627179)Laboratoires Thea2024-12-11
Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. (NCT06375499)Laboratoires Thea2024-09-17
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension (NCT06394973)Laboratoires Thea2024-08-05
Performance and Safety of T2769 in DED (NCT05965778)Laboratoires Thea2023-10-02
Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms. (NCT05931861)Laboratoires Thea2023-08-15
Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers (NCT05729594)Laboratoires Thea2023-02-27
Clinical Investigation to Evaluate the Tolerance of T10070 on Healthy Volunteers (NCT05622435)Laboratoires Thea2022-10-17
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. (NCT05389267)Laboratoires Thea2022-07-05
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients (NCT05397600)Laboratoires Thea2022-06-22
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) (NCT05176717)Laboratoires Thea2021-12-15
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) (NCT05158296)Laboratoires Thea2021-12-08
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa (NCT05085964)Laboratoires Thea2021-09-16
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients. (NCT04898387)Laboratoires Thea2021-03-26
Macula Evolution in Patients With AMD Taking Oral Food Supplementation (NCT04778436)Laboratoires Thea2021-01-13
Gastrointestinal Tolerance Assessment of T2309 (NCT04596605)Laboratoires Thea2020-07-15
Efficacy and Tolerability of Blephademodex Wipes (NCT04780165)Laboratoires Thea2019-09-11
Extension Study to Study PQ-110-001 (NCT03140969) (NCT03913130)Laboratoires Thea2019-05-13
Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment (NCT04803240)Laboratoires Thea2019-04-01
Efficacy, Safety of T2769 in Dry Eye Disease (NCT03830359)Laboratoires Thea2018-09-01
Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene (NCT03140969)Laboratoires Thea2017-10-16

Track Laboratoires Thea automatically

Every clearance here is in the API, with alerts when new ones post.